3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
HER2-positive Breast Cancer
2
Colorectal Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Hemangiosarcoma
1
HER2-positive Metastatic Breast Cancer
1
Brain Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma
1
Interventions
pembrolizumab
14
Cisplatin
12
Specimen Handling
11
Radiotherapy
7
Magnetic Resonance Spectroscopy
7
Brachytherapy
7
Bevacizumab
7
Human Papillomavirus DNA Tests
6
atezolizumab
5
Platinum
5
Paclitaxel
5
Nivolumab
5
Gemcitabine
5
Colposcopy
5
Carboplatin
5
Blood Specimen Collection
5
Radiation
4
Fulvestrant
4
lenvatinib
3
Surveys and Questionnaires
3
Restraint, Physical
3
Radiation Dose Hypofractionation
3
Drug Therapy
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
zimberelimab
2
tisotumab vedotin
2
spartalizumab
2
palbociclib
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
tucatinib
×
90 days
×
Clear all
No trials found.